RxDoctor Payments Data

Karen Holdsworth, NP

Nurse Practitioner · Graham, NCNPI 1104454842

Payments from drug & device makers

$3,349in general payments, 2019–2025

Across 184 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$506
  • Novo Nordisk$445
  • AstraZeneca$415
  • Pfizer$414
  • Boehringer Ingelheim$255
  • AbbVie$185
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$3,349100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,349 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$21,857
Medicare patients
66
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$89,932
JardianceEmpagliflozin49$65,753
RybelsusSemaglutide23$39,686
TrulicityDulaglutide29$35,124
EliquisApixaban29$32,558
FarxigaDapagliflozin Propanediol23$26,631
MounjaroTirzepatide14$26,100
SymbicortBudesonide/Formoterol Fumarate20$6,693
BelsomraSuvorexant14$6,178
Breo ElliptaFluticasone/Vilanterol12$4,680
Gabapentin120$2,657
Omeprazole125$2,613
Atorvastatin Calcium261$2,216
Rosuvastatin Calcium199$2,142
Albuterol Sulfate HfaAlbuterol Sulfate62$1,583

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$445$129,618102 claims
Boehringer IngelheimJardiance$255$65,75349 claims
Lilly USA, LLCTrulicity, Mounjaro$506$61,22443 claims
AstraZenecaFarxiga, Symbicort$415$33,32443 claims
PfizerEliquis$414$32,55829 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Graham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →